Literature DB >> 18583114

Mixed PEG-PE/vitamin E tumor-targeted immunomicelles as carriers for poorly soluble anti-cancer drugs: improved drug solubilization and enhanced in vitro cytotoxicity.

Rupa R Sawant1, Rishikesh M Sawant, Vladimir P Torchilin.   

Abstract

Two poorly soluble, potent anti-cancer drugs, paclitaxel and camptothecin, were successfully solubilized by mixed micelles of polyethylene glycol-phosphatidyl ethanolamine (PEG-PE) and vitamin E. Drug-containing micelles were additionally modified with anti-nucleosome monoclonal antibody 2C5 (mAb 2C5), which can specifically bring micelles to tumor cells in vitro. The optimized micelles had an average size of about 13-22 nm and the immuno-modification of micelles did not significantly change it. The solubilization of both drugs by the mixed micelles was more efficient than by micelles made of PEG-PE alone. Solubilization of camptothecin in micelles prevented also the hydrolysis of active lactone form of the drug to inactive carboxylate form. Drug-loaded mixed micelles and mAb 2C5-immunomicelles demonstrated significantly higher in vitro cytotoxicity than free drug against various cancer cell lines.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18583114      PMCID: PMC2603419          DOI: 10.1016/j.ejpb.2008.04.016

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  47 in total

1.  TAT peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitors.

Authors:  V P Torchilin; R Rammohan; V Weissig; T S Levchenko
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-03       Impact factor: 11.205

2.  Camptothecin delivery systems: the utility of amino acid spacers for the conjugation of camptothecin with polyethylene glycol to create prodrugs.

Authors:  C D Conover; R B Greenwald; A Pendri; K L Shum
Journal:  Anticancer Drug Des       Date:  1999-12

Review 3.  Structure and design of polymeric surfactant-based drug delivery systems.

Authors:  V P Torchilin
Journal:  J Control Release       Date:  2001-06-15       Impact factor: 9.776

4.  Influence of cationic lipids on the stability and membrane properties of paclitaxel-containing liposomes.

Authors:  R B Campbell; S V Balasubramanian; R M Straubinger
Journal:  J Pharm Sci       Date:  2001-08       Impact factor: 3.534

Review 5.  Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review.

Authors:  H Maeda; J Wu; T Sawa; Y Matsumura; K Hori
Journal:  J Control Release       Date:  2000-03-01       Impact factor: 9.776

6.  Immunomicelles: targeted pharmaceutical carriers for poorly soluble drugs.

Authors:  Vladimir P Torchilin; Anatoly N Lukyanov; Zhonggao Gao; Brigitte Papahadjopoulos-Sternberg
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-25       Impact factor: 11.205

Review 7.  Current perspectives on the clinical experience, pharmacology, and continued development of the camptothecins.

Authors:  Rocio Garcia-Carbonero; Jeffrey G Supko
Journal:  Clin Cancer Res       Date:  2002-03       Impact factor: 12.531

8.  PEG-PE/phosphatidylcholine mixed immunomicelles specifically deliver encapsulated taxol to tumor cells of different origin and promote their efficient killing.

Authors:  Z Gao; A N Lukyanov; A R Chakilam; V P Torchilin
Journal:  J Drug Target       Date:  2003-02       Impact factor: 5.121

9.  A versatile prodrug approach for liposomal core-loading of water-insoluble camptothecin anticancer drugs.

Authors:  Xinli Liu; Bert C Lynn; Junhong Zhang; Lin Song; David Bom; Wu Du; Dennis P Curran; Thomas G Burke
Journal:  J Am Chem Soc       Date:  2002-07-03       Impact factor: 15.419

10.  Evaluation of PLGA microspheres as delivery system for antitumor agent-camptothecin.

Authors:  Wenkai Tong; Lejun Wang; Martin J D'Souza
Journal:  Drug Dev Ind Pharm       Date:  2003-08       Impact factor: 3.225

View more
  17 in total

1.  Preferential cellular uptake of amphiphilic macromolecule-lipid complexes with enhanced stability and biocompatibility.

Authors:  Alexander M Harmon; Melissa H Lash; Sarah M Sparks; Kathryn E Uhrich
Journal:  J Control Release       Date:  2011-04-14       Impact factor: 9.776

2.  Optimization of Weight Ratio for DSPE-PEG/TPGS Hybrid Micelles to Improve Drug Retention and Tumor Penetration.

Authors:  Ya Jin; Zimei Wu; Caibin Li; Weisai Zhou; John P Shaw; Bruce C Baguley; Jianping Liu; Wenli Zhang
Journal:  Pharm Res       Date:  2018-01-04       Impact factor: 4.200

3.  Accumulation and toxicity of antibody-targeted doxorubicin-loaded PEG-PE micelles in ovarian cancer cell spheroid model.

Authors:  Federico Perche; Niravkumar R Patel; Vladimir P Torchilin
Journal:  J Control Release       Date:  2012-09-10       Impact factor: 9.776

4.  Polyethylene glycol-phosphatidylethanolamine (PEG-PE)/vitamin E micelles for co-delivery of paclitaxel and curcumin to overcome multi-drug resistance in ovarian cancer.

Authors:  Abraham H Abouzeid; Niravkumar R Patel; Vladimir P Torchilin
Journal:  Int J Pharm       Date:  2014-01-17       Impact factor: 5.875

5.  Pegylated Phthalocyanines: Synthesis and Spectroscopic Properties.

Authors:  Hairong Li; Frank R Fronczek; M Graça H Vicente
Journal:  Tetrahedron Lett       Date:  2011-12-14       Impact factor: 2.415

6.  Peptide contour length determines equilibrium secondary structure in protein-analogous micelles.

Authors:  Rachel Marullo; Mark Kastantin; Laurie B Drews; Matthew Tirrell
Journal:  Biopolymers       Date:  2013-09       Impact factor: 2.505

7.  Transferrin-targeted polymeric micelles co-loaded with curcumin and paclitaxel: efficient killing of paclitaxel-resistant cancer cells.

Authors:  Abraham H Abouzeid; Niravkumar R Patel; Can Sarisozen; Vladimir P Torchilin
Journal:  Pharm Res       Date:  2014-02-13       Impact factor: 4.200

8.  Effect of the lipid chain melting transition on the stability of DSPE-PEG(2000) micelles.

Authors:  Mark Kastantin; Badriprasad Ananthanarayanan; Priya Karmali; Erkki Ruoslahti; Matthew Tirrell
Journal:  Langmuir       Date:  2009-07-07       Impact factor: 3.882

9.  The effect of co-delivery of paclitaxel and curcumin by transferrin-targeted PEG-PE-based mixed micelles on resistant ovarian cancer in 3-D spheroids and in vivo tumors.

Authors:  Can Sarisozen; Abraham H Abouzeid; Vladimir P Torchilin
Journal:  Eur J Pharm Biopharm       Date:  2014-07-10       Impact factor: 5.571

Review 10.  Nanomicellar carriers for targeted delivery of anticancer agents.

Authors:  Xiaolan Zhang; Yixian Huang; Song Li
Journal:  Ther Deliv       Date:  2014-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.